Perseus Proteomics Inc.
HOMECorporate ProfileResearch & DevelopmentProduct Information
Corporate Profile
News
2013/6/10
Preclinical evaluation of RI labelled anti CDH3 antibody received First Place Poster Award at SNMMI2013.
Perseus Proteomics Inc.


Preclinical evaluation of RI labelled anti CDH3 antibody received First Place Poster Award at SNMMI2013.

PPMX presented a research progress regarding anti cancer therapeutic agent FF-21101 (RI labelled anti CDH3 antibody) under the collaboration with FUJIFILM RI Pharma Co., Ltd. at the Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2013 Annual Meeting. The award is " FIRST PLACE POSTER" categorized as Oncology: Basic, Translational & Therapy.